News

OptiBiotix Health - LP-LDL? news media interest in USA

OptiBiotix Health · OPTI1 May 2018

OptiBiotix Health plc, a life sciences business developing compounds to tackle obesity, high cholesterol, diabetes and skin care, announces that it has become aware of news reports on its LP-LDL ® product in the USA. The media interest has been generated by a potential commercial partner, Seed Health, who have purchased LP-LDL ® for use in its multi-strain...

OptiBiotix Health plc, a life sciences business developing compounds to tackle obesity, high cholesterol, diabetes and skin care, announces that it has become aware of news reports on its LP-LDL ® product in the USA. The media interest has been generated by a potential commercial partner, Seed Health, who have purchased LP-LDL ® for use in its multi-strain...

Share